\begin{longtable}{lcccccc}
\caption{Inference for Day 29antibody marker covariate-adjusted correlates of risk of COVID in the vaccine group: Hazard ratios per 10-fold increment in the marker*} \\ 
   \hline
 
         \multicolumn{1}{l}{COVEBoost} & \multicolumn{1}{c}{No. cases /}   & \multicolumn{2}{c}{HR per 10-fold incr.}                     & \multicolumn{1}{c}{P-value}   & \multicolumn{1}{c}{q-value}   & \multicolumn{1}{c}{FWER} \\ 
         \multicolumn{1}{l}{Immunologic Marker}            & \multicolumn{1}{c}{No. at-risk**} & \multicolumn{1}{c}{Pt. Est.} & \multicolumn{1}{c}{95\% CI} & \multicolumn{1}{c}{(2-sided)} & \multicolumn{1}{c}{***} & \multicolumn{1}{c}{} \\ 
         \hline
 
    BD29bindSpike\_BA.1 & 573/4,013 & 0.56 & (0.38-0.80) & 0.002 & $<$0.001 & $<$0.001 \\ 
  BD29pseudoneutid50\_BA.1 & 573/4,013 & 0.39 & (0.23-0.68) & $<$0.001 & $<$0.001 & $<$0.001 \\ 
   \hline
\hline
\label{tab:CoR_univariable_svycoxph_pretty}
\end{longtable}
